Physician profile
Clinton K Atkinson
NPI 1083620280
$2,448.61
in general payments reported to CMS, 2019-2025
15 companies · $995 in 2025
The $995 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $131 · 2021: $70.85 · 2022: $199 · 2023: $278 · 2024: $391 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422 · Travel and Lodging: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.36 |
| Travel and Lodging | $241.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,379.36 | 2021-2025 | Mo.Ma Ultra, Endurant Iis, In.Pact Av |
| Ethicon US, LLC | $181.30 | 2025 | Evarrest, Vistaseal |
| Medtronic Vascular, INC. | $177.17 | 2019 | |
| Silk Road Medical, INC. | $168.75 | 2019 | |
| Venclose INC. | $130.56 | 2020 | |
| Organogenesis INC. | $124.62 | 2022-2023 | Puraply |
| W. L. Gore & Associates, INC. | $73.79 | 2023-2025 | Gore Viabahn Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Cook Medical LLC | $50.12 | 2023-2025 | Zenith Alpha, Zenith Spiral-Z |
| Abbott Laboratories | $41.68 | 2019-2024 | Eterna |
| Solventum Corporation | $31.49 | 2024 | Activ.A.C. |
| Boston Scientific Corporation | $28.79 | 2025 | Wavewriter Alpha Prime 16 |
| Shockwave Medical, INC | $20.45 | 2022 | |
| Covidien LP | $20.12 | 2019 | |
| Pfizer INC. | $14.56 | 2022 | |
| Cashflow Solutions, LLC | $5.85 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Atkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.